The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEO.L Regulatory News (APEO)

  • There is currently no data for APEO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Name

29 Apr 2024 16:53

RNS Number : 4706M
abrdn Private Equity Opp Trst plc
29 April 2024
 

abrdn Private Equity Opportunities Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

29 April 2024

 

Change of Name

The Board of abrdn Private Equity Opportunities Trust plc (the "Company") notes the press release made today by abrdn plc in respect of the completion of the sale of its European-headquartered Private Equity business including the Company's investment manager, abrdn Capital Partners LLP ("abrdn Capital Partners"), to Patria Investments Ltd ("Patria"), a global alternative asset manager (the "Transaction").

As announced at the Company's AGM on 27 March 2024, following an extensive due diligence process, the Board consented to the Transaction by waiving the "Manager Change of Control" provisions set out in the Company's investment management agreement with abrdn Capital Partners. 

The Company will continue to be managed by abrdn Capital Partners (which has been renamed Patria Capital Partners LLP), which is now an indirect subsidiary of Patria. 

With immediate effect:

· the Company's name will change to Patria Private Equity Trust plc;

· the Company's registered office will change to 16 Charlotte Square, Edinburgh, EH2 4DF;

· the Company secretary will change to GPMS Corporate Secretary Limited (an indirect subsidiary of Patria); and

· the Company's website will change to https://patriaprivateequitytrust.com/

The Company has requested that the FCA and the LSE update their records for the Company's new name and to apply a new ticker (PPET) as soon as practicable, which is expected to take effect on Wednesday, 1 May 2024.

Alan Devine, the Company's Chair, said:

"As I mentioned at the Company's AGM in March, the Board has undertaken extensive due diligence in respect of the Transaction. We are delighted that the Transaction is not going to result in any changes to: (i) the Company's management and administration services; (ii) the Company's investment management process; or (iii) the personnel managing and servicing the Company. 

The Company will now be known as Patria Private Equity Trust plc to align more closely to the Patria brand. This is an exciting period for the Company as we continue to rely upon the existing attributes of our Manager whilst also reaping the benefits of Patria's wider geographical reach and private equity experience thus enabling us to build upon the Company's growth and performance since its establishment in 2001.

The Board is excited for the next stage of the Company's journey, and what Patria's involvement will bring."

For further information, please contact:

Patria Private Equity Trust plc

 

Alan Devine (Chair)

 

 

via SEC Newgate

 

The Manager & Company Secretary

 

Alan Gauld (Lead Manager)

Paul Evitt (Company Secretary)

 

 

via SEC Newgate

via SEC Newgate

Dickson Minto Advisers

 

 

Douglas Armstrong

 

 

+44 (0)20 7649 6823

SEC Newgate

Sally Walton

 

 

+44 (0)20 3757 6872

apeot@secnewgate.co.uk

Notes:

About Patria Investments

Patria is a global alternative investment firm with over 35 years of history and, following completion of the Transaction, has combined assets under management of over $40 billion, and a global presence with offices in 12 cities across 4 continents. Further information is available at www.patria.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANILMATMTATBBI
Date   Source Headline
9th Jun 20237:00 amRNSNotice of Results
17th May 202311:51 amRNSHolding(s) in Company
17th May 20237:00 amRNSEstimate NAV at 30 April 2023
25th Apr 202311:52 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNSEstimated NAV at 31 March 2023
11th Apr 202311:23 amRNSQuarterly disclosure
22nd Mar 20231:41 pmRNSResult of AGM
16th Mar 20237:00 amRNSEstimated NAV at 28 February 2023
9th Mar 20237:00 amRNSFirst Interim Dividend
14th Feb 20237:00 amRNSEstimated NAV at 31 January 2023
10th Feb 20238:57 amRNSDoc re. Annual Financial Report
9th Feb 20234:40 pmRNSSecond Price Monitoring Extn
9th Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 202311:38 amRNSDirector/PDMR Shareholding
31st Jan 202310:49 amRNSAnnual Financial Report
31st Jan 20237:00 amRNSAnnual Financial Report
18th Jan 20232:10 pmRNSNotice of Results
18th Jan 20237:00 amRNSEstimated NAV at 31 December 2022
9th Jan 20238:51 amRNSQuarterly disclosure
15th Dec 20227:00 amRNSEstimated NAV at 30 November 2022
13th Dec 20223:18 pmRNSFourth Interim Dividend Announcement
28th Nov 20227:01 amRNSCompany Secretary - Change of Name
21st Nov 20224:36 pmRNSPrice Monitoring Extension
14th Nov 20227:00 amRNSEstimated NAV at 31 October 2022
2nd Nov 20222:13 pmRNSDirector/PDMR Shareholding
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:36 pmRNSPrice Monitoring Extension
28th Oct 20229:42 amRNSEdison update on abrdn Private Equity Opp Trst
24th Oct 20224:41 pmRNSSecond Price Monitoring Extn
24th Oct 20224:36 pmRNSPrice Monitoring Extension
14th Oct 20227:00 amRNSEstimated NAV at 30 September 2022
10th Oct 20227:00 amRNSIncrease of Loan Facility
7th Oct 202210:33 amRNSQuarterly disclosure
16th Sep 20224:35 pmRNSPrice Monitoring Extension
15th Sep 20227:00 amRNSEstimated NAV at 31 August 2022
9th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20224:36 pmRNSResearch from QuotedData
8th Sep 202211:21 amRNSDirector/PDMR Shareholding
8th Sep 202210:11 amRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSThird Interim Dividend
12th Aug 20227:00 amRNSEstimated NAV at 31 July 2022
10th Aug 20225:49 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSEdison issues review on Abrdn Private Equity Opp.
21st Jul 20224:35 pmRNSPrice Monitoring Extension
14th Jul 202210:26 amRNSDoc re. Half Yearly Report
14th Jul 20227:00 amRNSEstimated NAV at 30 June 2022
5th Jul 20222:18 pmRNSQuarterly disclosure
30th Jun 20224:36 pmRNSPrice Monitoring Extension
30th Jun 20227:00 amRNSHalf-year Report
16th Jun 20227:00 amRNSEstimated NAV at 31 May 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.